Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Scott Levy currently holds 53,300 shares of Mineralys Therapeutics, Inc. (MLYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Scott Levy has been a net seller of MLYS stock. They have purchased $151.5K and sold $8.8M worth of shares.
Adam Scott Levy's most recent insider trade was on Feb 19, 2026, when they sold 53,300 shares at $0.00 per share.
Adam Scott Levy serves as Executive at Mineralys Therapeutics, Inc. (MLYS). They have executed 29 insider transactions totaling $8.9M over their tenure at the company.
Adam Scott Levy holds the position of Executive at Mineralys Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Adam Scott Levy has shown a selling trading pattern, with $151.5K in total purchases and $8.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Adam Scott Levy was on Nov 11, 2025, when they sold $1.8M worth of MLYS shares. This transaction involved 38,900 shares at $45.93 per share.
Adam Scott Levy currently owns 53,300 shares of Mineralys Therapeutics, Inc. (MLYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Scott Levy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Scott Levy has 29 Form 4 filings on record as an insider at Mineralys Therapeutics, Inc..
Set alerts for Adam Scott Levy and 40,000+ other insiders.